For a particular subgroup of individuals with severe paraphilic disorders and a high risk of sexual recidivism, the combination of sex drive-reducing medications and psychotherapy is a promising treatment approach. The present quasi-experimental study aims at comparing differences in clinical characteristics and dynamic risk factors between persons receiving (+TLM, n = 38) versus not receiving (-TLM, n = 22) testosterone-lowering medications (TLMs). Individuals receiving TLM were more frequently diagnosed with paraphilic disorders. Neither the criminal history nor average risk scores differed between the two groups. In the +TLM, Stable-2007 scores showed a stronger decrease after TLM treatment was started. This accounted especially for the general and sexual self-regulation subscales. Individual variations in risk, however, were not predicted by TLM but were significantly related to treatment duration and Psychopathy Checklist-Revised (PCL-R) Factor I. Paraphilic patients with problems in self-regulatory abilities seem to profit most from pharmacological sex drive-reducing treatment. Furthermore, therapists seem to underestimate deviant sexual fantasies in medicated patients.

中文翻译：

---

降睾酮药物及其与性犯罪者再犯风险的关系

对于患有严重性嗜好症和性再犯风险高的特定亚群，降低性欲的药物和心理治疗相结合是一种很有前景的治疗方法。本准实验研究旨在比较接受（+TLM，n = 38）与未接受（-TLM，n = 22）降睾酮药物（TLM）的人之间临床特征和动态风险因素的差异。接受 TLM 的个体更常被诊断出患有嗜酸性粒细胞疾病。两组之间的犯罪历史和平均风险评分均无差异。在+TLM 中，开始TLM 治疗后，Stable-2007 分数显示出更强的下降。这尤其说明了一般和性自我调节分量表。然而，风险的个体差异，不是由 TLM 预测的，但与治疗持续时间和精神病检查表修订 (PCL-R) 因子 I 显着相关。自我调节能力有问题的嗜好性患者似乎从药物性欲降低治疗中获益最多。此外，治疗师似乎低估了用药患者的异常性幻想。